To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
Clinical trial NCT03413384 · COMPLETED
Trial details
- NCT number
- NCT03413384
- Sponsor
- BrainX Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2025-07-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.